Highlights
TSXV: NTB       Neptune Technologies & B
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
Average Price Target: 7.00
Price Target Upside/Downside: +7.00

Headlines



No recent Headlines for this stock.


Business Background

Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company's products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).

  Be the first to like this.
 


 

890  748  1234  1712 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CVE 12.33+0.88 
 ECA 5.35+0.16 
 MFC 25.45+0.35 
 CNQ 38.91+2.00 
 HOD 3.975-0.095 
 CPG 4.80+0.19 
 BTE 1.50+0.05 
 SU 42.35+1.53 
 MRS 0.105+0.02 
 ARX 7.48+0.48 
Partners & Brokers